Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
A sharp move has pushed LTR Pharma Ltd (ASX:LTP) back into focus, with the stock rising 14.89% to AUD 0.54. But the percentage gain is only the first layer of the story. The more useful question is what has changed in the underlyingBusinessand which …
Vitrafy Life Sciences has continued progressing its cryopreservation technology platform as it works towards broader commercial adoption. The company is developing solutions designed to improve the storage and recovery of biological materials across healthcare and agriculture.
Optiscan Imaging has continued advancing its medical imaging technology platform through clinical studies, commercial initiatives and strategic collaborations. The company is focused on developing confocal endomicroscopy solutions that enable real-time tissue imaging for surgical, pathology and veterinary applications.
Clarity Pharmaceuticals shares were among the standout performers on the ASX on 10 August 2026, rising 4.46% according to a TradingView top-gainers screener, as the clinical-stage radiopharmaceutical developer rode ongoing sentiment from a trial update released five days earlier. The Sydney-headquartered company, which is …
EchoIQ shares were among the standout movers on the ASX this week, climbing 4.42% to feature on a TradingView top-gainers screener dated around 8-10 August 2026. For long-time watchers of the small-cap medtech, the move is less a one-off spike than the latest instalment …
EMVision Medical Devices climbed 4.37% in early-August trade, landing it among the ASX's top gainers on a screener dated 8-10 August 2026, with shares changing hands around AUD 1.68 and the company's market capitalisation sitting near AUD 149 million. There is no new ASX …
Nova Eye Medical shares were among the ASX's stronger movers this week, adding a further 6.45% on a TradingView top-gainers screener taken around 8-10 August 2026. It's the latest leg of a rally that has taken the small-cap glaucoma device maker from around 13 …
Alterity Therapeutics shares featured on a TradingView screener of ASX top gainers around 8-10 August 2026, up 4.85% on the day, a move that landed the stock on watchlists of small-cap biotech traders. The gain came against a backdrop of genuine regulatory progress rather …
Amplia Therapeutics added 3.33% on the day it surfaced among the ASX's small-cap gainers, a modest move for a clinical-stage biotech whose share price tends to swing on sentiment as much as news. No single company announcement was tied to the rise, and for …
The S&P/ASX 200 Health Care index (ASX:XHJ) added 0.76 per cent in the 10 August 2026 Australian Financial Review market snapshot, based on 20-minute delayed pricing, as investors backed away from the major banks and searched for growth in other parts of the market. …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…